Ten Capital Wealth Advisors’s Pulse Biosciences PLSE Stock Holding History

Ten Capital Wealth Advisors’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,000	Closed	-$6.72K	–	430
2023 Q1	$6.72K	Hold	2,000	–	–	﹤0.01%	401
2022 Q4	$5.54K	Hold	2,000	–	–	﹤0.01%	376
2022 Q3	$5K	Hold	2,000	–	–	﹤0.01%	409
2022 Q2	$3K	Hold	2,000	–	–	﹤0.01%	372
2022 Q1	$10K	Hold	2,000	–	–	﹤0.01%	294
2021 Q4	$30K	Hold	2,000	–	–	0.01%	182
2021 Q3	$43K	Hold	2,000	–	–	0.02%	143
2021 Q2	$33K	Buy	+2,000	New	+$38.1K	0.01%	207

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Ten Capital Wealth Advisors's PLSE Position: Q2 2023 in Review

Ten Capital Wealth Advisors sold out of Pulse Biosciences (PLSE) in Q2 2023, closing a stake of 2,000 shares — an estimated $6.72K sold.

Ten Capital Wealth Advisors first reported a position in PLSE in Q2 2021 and held it in 8 quarters. The position peaked at $43K in Q3 2021. 45 funds tracked by Wall St. Rank hold PLSE as of Q2 2023.

Ten Capital Wealth Advisors reported no remaining Pulse Biosciences position as of Q2 2023 after selling out during the quarter.
Ten Capital Wealth Advisors sold 2,000 Pulse Biosciences shares in Q2 2023, an estimated $6.72K.
Ten Capital Wealth Advisors first reported a position in Pulse Biosciences in Q2 2021 and held it in 8 quarters.
Ten Capital Wealth Advisors's Pulse Biosciences position peaked at $43K in Q3 2021.
45 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.